This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fulton, R. W. Articles by Frey, M. L. Search for Related Content PubMed PubMed Citation Articles by Fulton, R. W. Articles by Frey, M. L.

 Previous Article  |  Next Article 

Clinical and Diagnostic Laboratory Immunology, May 1997, 380-383, Vol 4, No. 3
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Neutralizing antibodies to type 1 and 2 bovine viral diarrhea viruses: detection by inhibition of viral cytopathology and infectivity by immunoperoxidase assay

RW Fulton, JT Saliki, LJ Burge, JM d'Offay, SR Bolin, RK Maes, JC Baker and ML Frey
Department of Infectious Diseases and Physiology, Oklahoma State University, Stillwater 74078, USA. RFULTON@OKWAY.OKSTATE.EDU

Neutralizing antibodies to type 1 and 2 bovine viral diarrhea virus (BVDV) strains were measured by a microtiter virus neutralization test (MVNT) in cell culture. Antibodies (neutralizing) were detected by inhibition of viral infectivity, by the absence of viral cytopathology for cytopathic strains, or by immunoperoxidase staining for noncytopathic strains. The immunoperoxidase-stained monolayers could be detected without the aid of light microscopy. Twenty BVDV strains were used as challenge viruses in the in vitro MVNT, including 14 type 1 and 6 type 2 strains. Representative noncytopathic and cytopathic strains of both types were used. Positive control serum samples available for diagnostic testing contained both type 1 and type 2 BVDV antibodies. There did not appear to be major differences in antibody titers among the respective type strains, regardless of biotype (cytopathic or noncytopathic). In a study with sera from calves receiving a modified live virus or inactivated BVDV vaccine, the calves receiving type 1 strains responded with higher antibody titers to type 1 strains than to type 2 strains.

This article has been cited by other articles:

• Wang, L., Sunyer, J. O., Bello, L. J. (2004). Fusion to C3d Enhances the Immunogenicity of the E2 Glycoprotein of Type 2 Bovine Viral Diarrhea Virus. J. Virol. 78: 1616-1622 [Abstract] [Full Text]